Relation of fibrinogen level with cardiovascular events in patients with coronary artery disease

American Journal of Cardiology

Volumn 111, Issue 6, 2013, Pages 804-810

  Ndrepepa, Gjin ^a   Braun, Siegmund ^a   King, Lamin ^a   Fusaro, Massimiliano ^a   Keta, Dritan ^c   Cassese, Salvatore ^a   Tada, Tomohisa ^a   Schömig, Albert ^a,b   Kastrati, Adnan ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c Krankenhaus Landshut Achdorf   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; STENT THROMBOSIS;

AGED; BIOLOGICAL MARKERS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FIBRINOGEN; HUMANS; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; RISK FACTORS; ROC CURVE; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS;

EID: 84884211438     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.11.060     Document Type: Article

References (17)

1. J. Danesh, S. Lewington, S.G. Thompson, G.D. Lowe, R. Collins, J.B. Kostis, A.C. Wilson, A.R. Folsom, K. Wu, M. Benderly, U. Goldbourt, J. Willeit, S. Kiechl, J.W. Yarnell, P.M. Sweetnam, P.C. Elwood, M. Cushman, B.M. Psaty, R.P. Tracy, A. Tybjaerg-Hansen, F. Haverkate, M.P. de Maat, F.G. Fowkes, A.J. Lee, F.B. Smith, V. Salomaa, K. Harald, R. Rasi, E. Vahtera, P. Jousilahti, J. Pekkanen, R. D'Agostino, W.B. Kannel, P.W. Wilson, G. Tofler, C.L. Arocha-Pinango, A. Rodriguez-Larralde, E. Nagy, M. Mijares, R. Espinosa, E. Rodriquez-Roa, E. Ryder, M.P. Diez-Ewald, G. Campos, V. Fernandez, E. Torres, R. Marchioli, F. Valagussa, A. Rosengren, L. Wilhelmsen, G. Lappas, H. Eriksson, P. Cremer, D. Nagel, J.D. Curb, B. Rodriguez, K. Yano, J.T. Salonen, K. Nyyssonen, T.P. Tuomainen, B. Hedblad, P. Lind, H. Loewel, W. Koenig, T.W. Meade, J.A. Cooper, B. De Stavola, C. Knottenbelt, G.J. Miller, K.A. Bauer, R.D. Rosenberg, S. Sato, A. Kitamura, Y. Naito, T. Palosuo, P. Ducimetiere, P. Amouyel, D. Arveiler, A.E. Evans, J. Ferrieres, I. Juhan-Vague, A. Bingham, H. Schulte, G. Assmann, B. Cantin, B. Lamarche, J.P. Despres, G.R. Dagenais, H. Tunstall-Pedoe, M. Woodward, Y. Ben-Shlomo, G. Davey Smith, V. Palmieri, J.L. Yeh, A. Rudnicka, P. Ridker, F. Rodeghiero, A. Tosetto, J. Shepherd, I. Ford, M. Robertson, E. Brunner, M. Shipley, E.J. Feskens, D. Kromhout, A. Dickinson, B. Ireland, K. Juzwishin, S. Kaptoge, A. Memon, N. Sarwar, M. Walker, J. Wheeler, I. White, and A. Wood Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis JAMA 294 2005 1799 1809
2. S. Kaptoge, E. Di Angelantonio, L. Pennells, A.M. Wood, I.R. White, P. Gao, M. Walker, A. Thompson, N. Sarwar, M. Caslake, A.S. Butterworth, P. Amouyel, G. Assmann, S.J. Bakker, E.L. Barr, E. Barrett-Connor, E.J. Benjamin, C. Bjorkelund, H. Brenner, E. Brunner, R. Clarke, J.A. Cooper, P. Cremer, M. Cushman, G.R. Dagenais, R.B. D'Agostino Sr., R. Dankner, G. Davey-Smith, D. Deeg, J.M. Dekker, G. Engstrom, A.R. Folsom, F.G. Fowkes, J. Gallacher, J.M. Gaziano, S. Giampaoli, R.F. Gillum, A. Hofman, B.V. Howard, E. Ingelsson, H. Iso, T. Jorgensen, S. Kiechl, A. Kitamura, Y. Kiyohara, W. Koenig, D. Kromhout, L.H. Kuller, D.A. Lawlor, T.W. Meade, A. Nissinen, B.G. Nordestgaard, A. Onat, D.B. Panagiotakos, B.M. Psaty, B. Rodriguez, A. Rosengren, V. Salomaa, J. Kauhanen, J.T. Salonen, J.A. Shaffer, S. Shea, I. Ford, C.D. Stehouwer, T.E. Strandberg, R.W. Tipping, A. Tosetto, S. Wassertheil-Smoller, P. Wennberg, R.G. Westendorp, P.H. Whincup, L. Wilhelmsen, M. Woodward, G.D. Lowe, N.J. Wareham, K.T. Khaw, N. Sattar, C.J. Packard, V. Gudnason, P.M. Ridker, M.B. Pepys, S.G. Thompson, and J. Danesh C-reactive protein, fibrinogen, and cardiovascular disease prediction N Engl J Med 367 2012 1310 1320
3. G. Luc, J.M. Bard, I. Juhan-Vague, J. Ferrieres, A. Evans, P. Amouyel, D. Arveiler, J.C. Fruchart, and P. Ducimetiere C-reactive protein, interleukin-6, and fibrinogen as predictors of coronary heart disease: the PRIME study Arterioscler Thromb Vasc Biol 23 2003 1255 1261
4. J.M. Sinning, C. Bickel, C.M. Messow, R. Schnabel, E. Lubos, H.J. Rupprecht, C. Espinola-Klein, K.J. Lackner, L. Tiret, T. Munzel, and S. Blankenberg Impact of C-reactive protein and fibrinogen on cardiovascular prognosis in patients with stable angina pectoris: the AtheroGene study Eur Heart J 27 2006 2962 2968
5. B. Keavney, J. Danesh, S. Parish, A. Palmer, S. Clark, L. Youngman, M. Delepine, M. Lathrop, R. Peto, and R. Collins Fibrinogen and coronary heart disease: test of causality by "Mendelian randomization." Int J Epidemiol 35 2006 935 943
6. G.L. Myers, R.H. Christenson, M. Cushman, C.M. Ballantyne, G.R. Cooper, C.M. Pfeiffer, S.M. Grundy, D.R. Labarthe, D. Levy, N. Rifai, and P.W. Wilson National Academy of Clinical Biochemistry laboratory medicine practice guidelines: emerging biomarkers for primary prevention of cardiovascular disease Clin Chem 55 2009 378 384
7. G. Ndrepepa, S. Braun, H.U. Haase, S. Schulz, S. Ranftl, M. Hadamitzky, J. Mehilli, A. Schomig, and A. Kastrati Prognostic value of uric acid in patients with acute coronary syndromes Am J Cardiol 109 2012 1260 1265
8. H. Sandler, and H.T. Dodge The use of single plane angiocardiograms for the calculation of left ventricular volume in man Am Heart J 75 1968 325 334
9. D.W. Cockcroft, and M.H. Gault Prediction of creatinine clearance from serum creatinine Nephron 16 1976 31 41
10. D.E. Cutlip, S. Windecker, R. Mehran, A. Boam, D.J. Cohen, G.A. van Es, P.G. Steg, M.A. Morel, L. Mauri, P. Vranckx, E. McFadden, A. Lansky, M. Hamon, M.W. Krucoff, and P.W. Serruys Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351
11. M.J. Pencina, R.B. D'Agostino Sr., R.B. D'Agostino Jr., and R.S. Vasan Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond Stat Med 27 2008 157 172
12. S. Losner, B.W. Volk, and N.D. Wilensky Fibrinogen concentration in acute myocardial infarction; comparison of the clot density determination of fibrinogen with the erythrocyte sedimentation rate AMA Arch Intern Med 93 1954 231 245
13. S. Kamath, and G.Y. Lip Fibrinogen: biochemistry, epidemiology and determinants QJM 96 2003 711 729
14. W. Koenig Fibrin(ogen) in cardiovascular disease: an update Thromb Haemost 89 2003 601 609
15. J.P. Empana, X. Jouven, F. Canoui-Poitrine, G. Luc, M. Tafflet, B. Haas, D. Arveiler, J. Ferrieres, J.B. Ruidavets, M. Montaye, J. Yarnell, P. Morange, F. Kee, A. Evans, P. Amouyel, and P. Ducimetiere C-reactive protein, interleukin 6, fibrinogen and risk of sudden death in European middle-aged men: the PRIME study Arterioscler Thromb Vasc Biol 30 2010 2047 2052
16. A.R. Folsom Fibrinogen and cardiovascular risk markers Blood Coagul Fibrinolysis 10 suppl 1999 S13 S16
17. R.P. Tracy, A.M. Arnold, W. Ettinger, L. Fried, E. Meilahn, and P. Savage The relationship of fibrinogen and factors VII and VIII to incident cardiovascular disease and death in the elderly: results from the cardiovascular health study Arterioscler Thromb Vasc Biol 19 1999 1776 1783